catalog number :
MBS7604620
products full name :
SUMF1 Rabbit Polyclonal
products short name :
[SUMF1]
products name syn :
[AAPA3037, FGE, sulfatase modifying factor 1, SUMF1, UNQ3037/PRO9852]
other names :
[sulfatase-modifying factor 1 isoform 3; Sulfatase-modifying factor 1; sulfatase-modifying factor 1; sulfatase modifying factor 1; C-alpha-formylglycine-generating enzyme 1]
products gene name :
[SUMF1]
other gene names :
[SUMF1; SUMF1; FGE; UNQ3037; AAPA3037; FGE]
uniprot entry name :
SUMF1_HUMAN
reactivity :
Human, Mouse
specificity :
Human, Mouse; other species are not tested. Please decide the specificity by homology.
purity :
>=95% as determined by SDS-PAGE. Immunogen Affinity Purified
storage stability :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20 degree C for 24 months (Avoid repeated freeze / thaw cycles.)
tested application :
ELISA (EIA), Western Blot (WB)
app notes :
WB: 1:500-1:2000
image1 heading :
Western Blot
other info1 :
Immunogen: Sulfatase modifying factor 1
products description :
Using molecular oxygen and an unidentified reducing agent, oxidizes a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also called C(alpha)-formylglycine. Known substrates include GALNS, ARSA, STS and ARSE.
ncbi acc num :
NP_001158147.1
ncbi gb acc num :
NM_001164675.1
ncbi pathways :
Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation Pathway (1268702); Glycosphingolipid Metabolism Pathway (1270099); Lysosome Pathway (99052); Lysosome Pathway (96865); Metabolism Pathway (1269956); Metabolism Of Lipids And Lipoproteins Pathway (1270001); Metabolism Of Proteins Pathway (1268677); Post-translational Protein Modification Pathway (1268701); Sphingolipid Metabolism Pathway (1270097); The Activation Of Arylsulfatases Pathway (1268709)
ncbi summary :
This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
uniprot summary :
SUMF1: Using molecular oxygen and an unidentified reducing agent, oxidizes a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also called C(alpha)-formylglycine. Known substrates include GALNS, ARSA, STS and ARSE. Defects in SUMF1 are the cause of multiple sulfatase deficiency (MSD). MSD is a clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Inheritance is autosomal recessive. Belongs to the sulfatase-modifying factor family. 3 isoforms of the human protein are produced by alternative splicing. Protein type: Oxidoreductase; Secreted; EC 1.8.99.-; Endoplasmic reticulum; Secreted, signal peptide. Chromosomal Location of Human Ortholog: 3p26.1. Cellular Component: endoplasmic reticulum lumen. Molecular Function: metal ion binding; oxidoreductase activity; protein homodimerization activity. Biological Process: glycosphingolipid metabolic process; post-translational protein modification. Disease: Multiple Sulfatase Deficiency